Title here

Text here

Dana-Farber Cancer Institute, Inc.

 

Boston, MA

GuideStar Quick View Everything you need to know...

Dana-Farber Cancer Institute, Inc.

Physical Address:
Boston, MA 02115 
EIN:
04-2263040
Web URL:
www.dana-farber.org
Leadership:
Dr. Edward J. Benz, Jr.
Detailed Financial and People Data included in the GuideStar Premium Report Report Added To Cart

Legitimacy Information

  • This organization is registered with the IRS.
  • This organization is required to file an IRS Form 990 or 990-EZ.

Institutional funders should note that an organization’s inclusion on GuideStar.org does not satisfy IRS Rev. Proc. 2011-33 for identifying supporting organizations.

Learn more about GuideStar Charity Check, the only pre-grant due diligence tool that is 100% compliant with IRS Rev. Proc 2011-33.


Forms 990 from IRS Additional Information IRS Form 990 is an annual document used by approximately one-third of all public charities to report information about their finances and operations to the federal government. GuideStar uses data from Form 990 to populate its database with financial information about nonprofit organizations. Posting Form 990 images on the GuideStar Web site is an ongoing process.

Forms 990 for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

A multi-year analysis of key balance sheet, income statement, profitability and liquidity measures is available for this organization. Financial SCAN includes a detailed financial health analysis and peer comparison and benchmarking tool. Learn More

Financial SCAN

Financial SCAN

Key Financial SCAN Features

  • Financial Health Dashboard: Highlights key financial trends and ratios for a selected nonprofit organization over a period of up to five years.
  • Peer Comparison Dashboard: Compares the organization's financials with up to five peer nonprofits that you select.
  • Graphical Analysis: Provides multi-year graphs and an interpretive guide in a format ready to present to your clients.
  • Printable PDF Report: Provides a complete analysis of the organization for your records. The full report tells you what to look for and why it matters.
  • Advanced Search: Allows you to search by EIN (Employer Identification Number), organization name, city, state, revenue, expenses, and assets.

Annual Revenue & Expenses Additional Information Financial information on GuideStar is either digitized from Form 990 images we receive from the IRS or submitted by the nonprofits themselves through the GuideStar Exchange (990 filers cannot override Form 990 financial data). If your organization does not file a Form 990, 990-EZ, or 990-PF and you would like to have your financial data displayed in this section, join the GuideStar Exchange today!

Fiscal Year Starting: Oct 01, 2011
Fiscal Year Ending: Sep 30, 2012
Revenue
Total Revenue $1,021,271,591
Expenses
Total Expenses $982,077,009

Is this information up-to-date?
Claim your report and update your GuideStar Exchange profile today!

Financial data from Forms 990 for Year 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

A multi-year analysis of key balance sheet, income statement, profitability and liquidity measures is available for this organization. Financial SCAN includes a detailed financial health analysis and peer comparison and benchmarking tool. Learn More

Financial SCAN

Financial SCAN

Key Financial SCAN Features

  • Financial Health Dashboard: Highlights key financial trends and ratios for a selected nonprofit organization over a period of up to five years.
  • Peer Comparison Dashboard: Compares the organization's financials with up to five peer nonprofits that you select.
  • Graphical Analysis: Provides multi-year graphs and an interpretive guide in a format ready to present to your clients.
  • Printable PDF Report: Provides a complete analysis of the organization for your records. The full report tells you what to look for and why it matters.
  • Advanced Search: Allows you to search by EIN (Employer Identification Number), organization name, city, state, revenue, expenses, and assets.

Boston Foundation


GuideStar Exchange Member

This organization is a Silver-level GuideStar Exchange participant, demonstrating its commitment to transparency.

Is this your organization's report?
Update your organization's information today!


Basic Organization Information

Dana-Farber Cancer Institute, Inc.

Physical Address:
Boston, MA 02115 
EIN:
04-2263040
Web URL:
www.dana-farber.org 
NTEE Category:
E Health—General & Rehabilitative 
E20 Hospitals and Primary Medical Care Facilities 
E Health—General & Rehabilitative 
E20 Hospitals and Primary Medical Care Facilities 
E Health—General & Rehabilitative 
E12 Fund Raising and/or Fund Distribution 
Ruling Year:
1962 

Sign in or create an account to see this organization's full address, contact information, and more!


Mission Statement

Founded in 1947, Dana-Farber Cancer Institute's mission is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations and disseminates innovative patient therapies and scientific discoveries in Boston, across the United States and throughout the world.

A multi-year analysis of key balance sheet, income statement, profitability and liquidity measures is available for this organization. Financial SCAN includes a detailed financial health analysis and peer comparison and benchmarking tool. Learn More

Financial SCAN

Financial SCAN

Key Financial SCAN Features

  • Financial Health Dashboard: Highlights key financial trends and ratios for a selected nonprofit organization over a period of up to five years.
  • Peer Comparison Dashboard: Compares the organization's financials with up to five peer nonprofits that you select.
  • Graphical Analysis: Provides multi-year graphs and an interpretive guide in a format ready to present to your clients.
  • Printable PDF Report: Provides a complete analysis of the organization for your records. The full report tells you what to look for and why it matters.
  • Advanced Search: Allows you to search by EIN (Employer Identification Number), organization name, city, state, revenue, expenses, and assets.


Revenue and Expenses

Revenue and Expense data from Forms 990 for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart


Balance Sheet

Balance Sheet data from Forms 990 for Year 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

A multi-year analysis of key balance sheet, income statement, profitability and liquidity measures is available for this organization. Financial SCAN includes a detailed financial health analysis and peer comparison and benchmarking tool. Learn More

Financial SCAN

Financial SCAN

Key Financial SCAN Features

  • Financial Health Dashboard: Highlights key financial trends and ratios for a selected nonprofit organization over a period of up to five years.
  • Peer Comparison Dashboard: Compares the organization's financials with up to five peer nonprofits that you select.
  • Graphical Analysis: Provides multi-year graphs and an interpretive guide in a format ready to present to your clients.
  • Printable PDF Report: Provides a complete analysis of the organization for your records. The full report tells you what to look for and why it matters.
  • Advanced Search: Allows you to search by EIN (Employer Identification Number), organization name, city, state, revenue, expenses, and assets.


Forms 990 Provided by the Nonprofit

Sign in or create an account to view Form(s) 990 for 2011, 2011, 2010.

Forms 990 Provided by the Nonprofit for 2011, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart


Financial Statements

Financial Statements for 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart


Annual Reports

Sign in or create an account to view this information.



Leadership (GuideStar ExchangeThe GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more. December, 2013)

Dr. Edward J. Benz, Jr.

Term:

Since Jan 2000

Profile:

Edward J. Benz, Jr., MD, became the president and chief executive officer of Dana-Farber in 2000 and also serves as chief executive officer of Dana-Farber/Partners Cancer Care, director of Dana-Farber/Harvard Cancer Center, and as a trustee of Dana-Farber/Children's Hospital Cancer Care. Dr. Benz is presently the Richard and Susan Smith Professor of Medicine, professor of Pediatrics, professor of Pathology, and faculty dean for Oncology at Harvard Medical School. He received a bachelor's degree, cum laude, from Princeton University; a medical degree, magna cum laude, from Harvard Medical School; and a master's degree (privatum) from Yale University. Immediately prior to assuming the presidency of the Institute, Dr. Benz was chairman of the Department of Medicine at the Johns Hopkins University School of Medicine and the Sir William Osler Professor of Medicine. Author of more than 200 articles, books, chapters, reviews, and abstracts, he is a past president of both the American Society of Hematology and the American Society of Clinical Investigation, and is currently an associate editor of the New England Journal of Medicine.



Officers for Fiscal Year (IRS Form 990)

Report Added To Cart Officers for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now


Highest Paid Employees & Their Compensation (IRS Form 990)

Highest Paid Employee Data for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart


Program: A. Patient Care

Budget:
--
Category:
Health Care, General/Other
Population Served:
Adults

Program Description:

Dana-Farber provides outpatient care to adult patients in 13 specialized centers and partners with Brigham and Women's Hospital to provide inpatient care. Pediatric patients receive outpatient care at our Jimmy Fund Clinic and inpatient care is provided by Children's Hospital Boston.

Program Long-Term Success:

U.S. News & World Report's Best Hospitals guide ranked Dana-Farber/Brigham and Women's Cancer Center the top cancer center in New England, for the 12th year in a row, and fifth overall in the country. Dana-Farber and Children's Hospital Boston was ranked as the #2 pediatric cancer hospital in the United States in its 2011-12 Best Children's Hospitals guide. This combined ranking reflects the clinical and scientific strength and depth of the Dana-Farber/Children's Hospital Cancer Center, a partnership of more than 60 years that provides comprehensive care to children with cancer and survivors of pediatric cancers.

Program Short-Term Success:

The Yawkey Center for Cancer Care, which opened in February 2011, adds 275,000 square feet of clinical and support space and is designed to accommodate more than 100 exam rooms, more than 150 infusion spaces, and 20 consultation rooms. This clinical care facilitywas designed with advice from patients, families, and staff to advance clinical care, optimize patient safety, enhance the patient experience, and provide an environment that fosters healing. Programs and resources such as our pioneering use of ERSA-C (Electronic Self-Report Assessment-Cancer), a first-of-its-kind computer program that helps patients track their symptoms and allow doctors to monitor them between visits, and our pilot of a real-time locating system to identify the locations of patients and staff and reduce wait times ensure that all of our patients' physical, emotional, and spiritual needs are met during and ease the burden of cancer treatment.

Program Success Monitored by:

We set standards for our own practices and measure ourselves against other comprehensive cancer centers nationwide. We measure five different aspects of patient care: effectiveness, patient and family satisfaction, safety, equitable access, and timeliness. In addition, U.S. News & World Report publishes its Best Hospitals guide each year as a reference for patients who are reviewing their medical care options. The overall score is based on professional reputation, mortality rates, patient safety, and a grouping of care-related factors such as nursing and patient services.

Program Success Examples:

At Griffin's 8-week checkup, his pediatrician found that his belly was abnormally large and sent him to Children's Hospital. After the test results came in, pediatric oncologist Dr. Lindsay Frazier met with the family to explain Griffin's cancer. This was a hard conversation for Griffin's parents, but Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) "had a psychologist available to speak with us, which helped emotionally," says Griffin's mother, Melissa. "And Dr. Frazier even called us at home the following Saturday to ask how we were managing." Griffin's cancer was called neuroblastoma and his care was transferred to two specialists at DF/CHCC. By the time he was 10 months old, Griffin had beaten cancer. Looking back, Melissa feels lucky to live so close to Dana-Farber. "I know it sounds odd, but I looked forward to going to the Jimmy Fund Clinic because we genuinely felt that everyone there cared about us. It was a good place for us during that period of our lives."

Program: B. Research

Budget:
--
Category:
Medical Research, General/Other
Population Served:
Adults
Children and Youth (0 - 19 years)

Program Description:

Research, both basic and clinical, remains at the core of our mission. Our researchers are currently trailblazing the concept of personalized medicine, tailoring therapies to each patient, to develop less invasive and toxic treatments.

Program Long-Term Success:

Dana-Farber is committed to translating basic research findings into clinical applications to ultimately improve treatments and outcomes for patients with all types of cancer. We seek to better understand drug resistance and disease relapse and overcome them through the continued development of targeted and effective ""smart"" drugs, which attack cancer cells but not normal ones. For example, in 2008, Dana-Farber scientists achieved a medical first by using a targeted drug to drive a patient's metastatic melanoma into remission. When lab tests showed the patient's tumor cells harbored a certain mutated gene, doctors treated her with a drug that blocks the gene's action, resulting in a dramatic reduction in tumor size and activity. In 2011, we received FDA approval for the first drug approved for advanced melanoma in more than 10 years. Over the next decade, the continued translation of our basic discoveries into informed drug development for more effective therapies is a top priority.

Program Short-Term Success:

In 2011, the Dana-Farber/Brigham and Women's Cancer Center boldly and successfully launched Profile, one of the most comprehensive cancer research studies to help accelerate the development of personalized treatments for every person with cancer to be undertaken nationally. This major research study tests all consenting adult patients' tumor tissue for nearly 500 genetic cancer-causing mutations in 41 cancer genes, using OncoMap technology, a novel screening approach discovered at Dana-Farber. The study will provide researchers with one of the world's largest databases of cancer genetic abnormalities. Over time, this growing body of information will help scientists discover more about the genetic causes of cancers and increase the development of new, targeted therapies to treat them.

Program Success Monitored by:

The Office of Research Support Services provides financial and administrative oversight for research at Dana-Farber. The Clinical Trials Office (CTO) develops policies, procedures, and best practices related to clinical trials; coordinates submission and compliance of protocols; assists in the pre-review of protocols before submission for approval; provides guidance related to the operational conduct of a trial, regulatory matters, and multi-center site issues; and facilitates clinical research center (CRC) recruitment, on-boarding and training and oversight and management of CRC teams. The goal of the CTO is to help assure that a clinical trial protocol is well written, able to be conducted at Dana-Farber and will meet the requirements for scientific review and Institutional Review Board.

Program Success Examples:

Dana-Farber's George Demetri, MD, designed and led an international Phase 3 clinical trial of regorafenib, a new targeted drug that can significantly control life-threatening metastatic disease in patients with gastrointestinal stromal tumors (GIST) that have developed resistance to Gleevec and Sutent, the only two FDA-approved drugs available for this disease. The trial determined that treatment with regorafenib reduces the risk of disease progression or death by more than 70 percent in these patients. In another trial, the novel compound selumetinib has become the first targeted therapy to benefit patients with the most common genetic subtype of lung cancer, non-small cell lung cancer. This study confirmed that chemotherapy and selumetinib might be an effective treatment for KRAS-mutant lung cancer and have implications for the treatment of all cancers that harbor KRAS mutations, including pancreatic and colorectal cancer.

Program: C. Training

Budget:
--
Category:
Medical Research, General/Other
Population Served:
Adults
Children and Youth (0 - 19 years)

Program Description:

A teaching affiliate of Harvard Medical School, DFCI supports participation by its professional staff in medical education, clinical training, and pre-doctoral and post-doctoral research training.

Program Long-Term Success:

Dana-Farber faculty are consistently recognized for their excellence in medical education, research and clinical training. The Institute offers formal opportunities for career development and implements diversity initiatives to increase the quality and balance of the professional lives of our young faculty. Examples of these innovative programs include the Office for Faculty Development, the Office of Diversity and Talent Management, both of which offer unique teaching and mentoring programs, and access to multiple multi-institutional programs such as those offered through Harvard Catalyst and Dana-Farber/Harvard Cancer Center. Contributing to our efforts to increase the pipeline of future cancer researchers, the Institute also supports instructional programs with high schools, colleges, and community groups that enable underserved students to work in Dana-Farber laboratories and begin their careers in science.

Program Short-Term Success:

Dana-Farber is keenly aware that future advances in cancer medicine lie in the imaginations of the talented physicians and scientists poised to be the leaders of tomorrow. The Postdoctoral and Graduate Student Affairs Office supports trainees' professional development through programs on manuscript writing, grant writing, and laboratory management. Dana-Farber attracts the finest researchers and clinicians in the world, and its junior faculty members benefit from extensive professional development opportunities. All members of the Institute's professional staff hold faculty appointments at Harvard University, and many participate as mentors for institutional graduate and postdoctoral training programs. It is a source of great pride that so many of Dana-Farber's former trainees are now principal investigators and institutional leaders here and at cancer centers around the world.

Program Success Monitored by:

Biannually, Dana-Farber's faculty and staff complete an opinion survey as part of efforts to create an ideal work environment. The survey consists of nearly 50 questions (some open-ended) on core values, work environment, organizational performance, diversity and inclusion, pay and benefits and supervisor/staff relationships. The purpose of the survey is to define levels of staff satisfaction/engagement, determine strengths and areas of opportunity, promote honest feedback, gauge if past actions/improvements have been successful and use the results to plan for future improvements. Results from the 2011 survey revealed that Dana-Farber scored 4.23 out of 5 for workplace satisfaction/commitment, outperforming national academic health care average and ranking in the 87th percentile of large academic medical health care organizations. High marks were received in quality care/service to patients, connection to the mission and values, and sense of pride in working for Dana-Farber.

Program Success Examples:

The Pediatric Hematology/Oncology Fellowship Program at Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) is one of the most recognized in the nation and has trained more leaders in the hematology and oncology field than any other. The program admits six new fellows per year who spend one year in full-time clinical work and two or more years in research training, depending on previous training and interests. The program is geared to broadly train MD or MD/PhD fellows in areas of clinical research, including outcomes, ethics, epidemiology, therapeutic trials and translational research, or in one of the major basic science disciplines: protein chemistry, structural biology, molecular biology, stem cell and developmental biology, genetics, genomics, immunology, systems biology, neuroscience or cell biology.

Program: D. Community Based Programs

Budget:
--
Category:
Health Care, General/Other
Population Served:
Poor/Economically Disadvantaged, Indigent, General
Adults
Children and Youth (0 - 19 years)

Program Description:

Dana-Farber promotes health in the Greater Boston community through its Community Benefits Program, which brings cancer education & resources to at-risk populations, and through its Center for Community-Based Research, which conducts research to reduce disparities in cancer care.

Program Long-Term Success:

The Institute's community benefits mission is threefold: to establish quantifiable and sustainable cancer prevention programs focusing on at-risk and underserved populations; provide expertise in cancer care to city and state health departments, community-based agencies and health care providers; and increase accrual of minorities into clinical trials. In addition to bringing cancer prevention, education and resources directly to diverse, at-risk, underserved populations, the Institute also conducts a broad scope of research to identify new interventions that reduce health disparities and improve access to care.

Program Short-Term Success:

Dana-Farber's Community Benefits Program aims to make Dana-Farber's care and research findings more accessible to everyone, including our neighbors in local communities. The Institute is committed to bringing cancer prevention and education initiatives to an increasing number of members of the Greater Boston community. Dana-Farber physicians are also committed to educating the public about cancer risk reduction, screening and early detection, and treatment options and survivorship. They reach out to Greater Boston communities to heighten awareness and answer questions through: ongoing presentations at partnering high schools; educational sessions to physicians and patients at community health centers; working with faith-based organizations and in collaboration with the Boston Ministerial Alliance; and speaking engagements to the elderly at low-income housing sites.

Program Success Monitored by:

To ensure that Dana-Farber's community outreach activities and programs are meeting the health needs in the community, Dana-Farber's Community Benefits Office partnered with Health Resources in Action (HRiA), a non-profit public health consultancy organization in Boston, to undertake a comprehensive community health assessment. In Phase I, social, economic, and epidemiological data at the community level were reviewed and analyzed to provide a health portrait of Dana-Farber's priority communities (Roxbury, Mission Hill, Dorchester, Mattapan, and Jamaica Plain). Phase II involved a comprehensive qualitative study, where Dana-Farber staff, community leaders, and residents provided feedback in focus groups and interviews to identify community needs and assets as well as areas for further community engagement and program expansion. The needs assessment final report was completed in early 2012.

Program Success Examples:

Dana-Farber's Mammography Van is the only mobile mammography program in the Commonwealth of Massachusetts. It provides screening mammograms and breast health education to women age 40 and older.In partnership with community-based organizations and neighborhood health centers, the Van serves all Boston neighborhoods and some surrounding towns. Skilled, board-certified mammography technologists from Dana-Farber perform the exams and films are interpreted by board-certified radiologists. By bringing Dana-Farber's high-quality services directly to the neighborhoods in which women live and work, the Van breaks down cultural, linguistic, financial, and logistical barriers to care and makes mammograms more accessible to women who might otherwise not have access to screening. Likewise, the Patient Navigator Program helps to remove barriers to cancer care for diverse women with low socio-economic status, limited English proficiency, disabilities, or lack of insurance.


Contractor data is available for this organization!

Independent Contractor information for 2012, 2011, 2010, 2009, 2008 is available for this organization with a subscription to GuideStar Premium Pro.

GuideStar Premium Pro also includes:

  • Comprehensive financial data, including functional expense detail, for every digitized fiscal year in GuideStar's database
  • Ability to download up to 55 fields of data for up to 1,000 organizations at a time and up to five years’ worth of Income Statement and Balance Sheet data for individual organizations
  • Comprehensive advanced search capabilities, including criteria for functional expenses, investible assets, investment income and audit & 990T filing requirements
  • Ability to save organizations and searches for quick reference
  • People search with salary range data
  • Access to all available Forms 990

More information

Upgrade Now!

Impact Summary from the Nonprofit

Ranked New England's best and the country's 5th best cancer hospital by U.S. News & World Report, Dana-Farber's equal commitment to research & patient care is unique among cancer institutions. This 50-50 balance results in extraordinary partnerships between laboratory scientists and clinicians to ensure that each patient's medical, psychological, family and spiritual needs are addressed throughout their entire cancer journey. Regardless of age, teams of multi-disciplinary experts focusing on the same type of cancer collaborate to offer novel therapies to patients and access to innovative clinical trials. Our network of support services is comprehensive and specialized to address unique patient needs at every stage of treatment and life. Last year, the Institute treated more than 47,000 adult patients through 350,000 visits in 13 specialized centers; and the Jimmy Fund Clinic treated more than 2,400 patients through nearly 15,000 visits.Dana-Farber's history of groundbreaking discoveries traces back to its founder, Dr. Sidney Farber, the ""father of chemotherapy"", and first physician to attain remissions of acute lymphoblastic leukemia, the most common childhood cancer. In the 1970s, our scientists pioneered combination chemotherapy, using multiple drugs to treat cancer more effectively. In the 1980s, the Institute was the first to implement autologous bone marrow transplantation, a life-saving procedure that reduces the risk of transplant rejection due to imperfect matches. Also in the 1980s, Dana-Farber scientists identified the human T-cell receptor, a key mechanism that led to vastly increased understanding of HIV/AIDS. In 2011, we launched Profile, one of the most extensive genotyping projects in cancer research nationally, allowing the Dana-Farber/Brigham and Women's Cancer Center to test all consenting patients' tumor tissue for nearly 500 cancer-causing mutations in 41 cancer genes and generate data to better understand the causes, treatments and prevention of cancer.

Organization Data Available

Adobe PDF Format A GuideStar Premium Report in PDF format is available for this organization

Price for this Report: $125.00

This Premium Report includes:

  • Financial Data for
  • Financial Charts for
  • Forms 990 for
  • Forms 990T for
  • Audited Financial Statement for
  • Annual Reports for
  • Letter of Determination
  • Form 1023 / 1024
  • Board Members
  • Officer, Director and/or Highest Paid Employee data for


Learn more about GuideStar Premium